Illumina, Inc. (ILMN) stock prices updated...
 

Illumina, Inc. stock price

Illumina, Inc. latest news:


  • 08/25/2017 09:45:50

    Illumina Teams Up With Telegraph Hill to Form Verogen

    Global leader in the field of DNA sequencing and array based technologies Illumina Inc ILMN along with Telegraph Hill Partners THP announced plans to set up an independent company Verogen Inc THP is a life science focused venture capital and growth equity firm based in

  • 08/01/2017 15:38:35

    Illumina shares rally as revenue tops Street view

    Illumina Inc. shares surged in the extended session Tuesday after the DNA sequencing company's quarterly revenue topped Wall Street estimates. Illumina shares rallied 9.5% to $188.50 after hours. The company reported second-quarter net income of $128 million, or 87 cents a share, compared to $120 million, or 82 cents a share, in the year-ago period. Adjusted earnings were 82 cents a share. Revenue rose to $662 million from $600 million in the year-ago period. Analysts surveyed by FactSet had estimated 82 cents a share on revenue of $642.2 million. For the year, Illumina estimates adjusted earnings of $3.60 to $3.70 a share. Analysts expect $3.63 a share.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • More trends:

    Image Sensing Systems, Inc.ISNS | Immersion CorporationIMMR | ImmuCell CorporationICCC | Immune Design Corp.IMDZ | Immune Pharmaceuticals Inc.IMNP | ImmunoGen, Inc.IMGN | Immunomedics, Inc.IMMU | Impax Laboratories, Inc.IPXL | Imprimis Pharmaceuticals, Inc.IMMY | INC Research Holdings, Inc.INCR |